Exact Sciences price target raised to $92 from $89 at Baird

Baird raised the firm’s price target on Exact Sciences to $92 from $89 and keeps an Outperform rating on the shares. The analyst said we continue to like the setup and would position the company as a top-tier idea for 2023, with Cologuard seeing strong momentum, the company’s profitability profile improving, and numerous data readouts ahead.